Gelonghui September 11丨Da Rentang (600329.SH) announced that the company plans to transfer 15% of the shares of Tianjin Pharmaceutical Group Finance Co., Ltd. through a public delisting method. The delisting price is RMB 87.823,86 million. If the transaction is successfully completed, the company's shareholding ratio in the finance company will be changed from 15% to 30%.
A finance company is a non-bank financial institution established with the approval of the China Banking Regulatory Commission to provide a financing platform, fund management and settlement platform for the company.